These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 30995806)
1. Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases. Ruder B; Atreya R; Becker C Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30995806 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment. Veltkamp C; Anstaett M; Wahl K; Möller S; Gangl S; Bachmann O; Hardtke-Wolenski M; Länger F; Stremmel W; Manns MP; Schulze-Osthoff K; Bantel H Gut; 2011 Oct; 60(10):1345-53. PubMed ID: 21459928 [TBL] [Abstract][Full Text] [Related]
3. Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. Blander JM FEBS J; 2016 Jul; 283(14):2720-30. PubMed ID: 27250564 [TBL] [Abstract][Full Text] [Related]
4. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation. Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262 [TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha. Ruemmele FM; Beaulieu JF; Dionne S; Levy E; Seidman EG; Cerf-Bensussan N; Lentze MJ Gut; 2002 Dec; 51(6):842-8. PubMed ID: 12427787 [TBL] [Abstract][Full Text] [Related]
6. TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats. Milia AF; Manetti M; Generini S; Polidori L; Benelli G; Cinelli M; Messerini L; Ibba-Manneschi L; Matucci-Cerinic M J Cell Mol Med; 2009 Jan; 13(1):164-76. PubMed ID: 18363845 [TBL] [Abstract][Full Text] [Related]
8. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD. He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Günther C; Neumann H; Neurath MF; Becker C Gut; 2013 Jul; 62(7):1062-71. PubMed ID: 22689519 [TBL] [Abstract][Full Text] [Related]
10. TNFα inhibitors restrict T cell activation and cycling via Notch-1 signalling in inflammatory bowel disease. Werner L; Berndt U; Paclik D; Danese S; Schirbel A; Sturm A Gut; 2012 Jul; 61(7):1016-27. PubMed ID: 22068169 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease. Crowe JS; Roberts KJ; Carlton TM; Maggiore L; Cubitt MF; Clare S; Harcourt K; Reckless J; MacDonald TT; Ray KP; Vossenkämper A; West MR Sci Rep; 2018 Mar; 8(1):4941. PubMed ID: 29563546 [TBL] [Abstract][Full Text] [Related]
12. Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice. Fukumoto K; Naito Y; Takagi T; Yamada S; Horie R; Inoue K; Harusato A; Hirata I; Omatsu T; Mizushima K; Hirai Y; Yoshida N; Uchiyama K; Ishikawa T; Handa O; Konishi H; Wakabayashi N; Yagi N; Kokura S; Ichikawa H; Kita M; Yoshikawa T Int J Mol Med; 2011 Mar; 27(3):353-9. PubMed ID: 21249312 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. Billmeier U; Dieterich W; Neurath MF; Atreya R World J Gastroenterol; 2016 Nov; 22(42):9300-9313. PubMed ID: 27895418 [TBL] [Abstract][Full Text] [Related]
14. Effects of Tumor Necrosis Factor Alpha Inhibitors on Lymph Node and Ileocecal Mucosa-Associated Lymphoid Tissue Architecture in Patients With Inflammatory Bowel Disease. Duncan VE; Chisholm KM; Pacheco MC Pediatr Dev Pathol; 2020; 23(2):115-120. PubMed ID: 31362580 [TBL] [Abstract][Full Text] [Related]